Financial News
Latest News about SRPT
Recent news which mentions SRPT
Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday
February 16, 2024
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 16, 2024
From Benzinga
2 Magnificent Growth Stocks to Buy With $500
February 15, 2024
From Motley Fool
Gene Therapy Player REGENXBIO's RGX-121 Marks Success In Trial, Yet Faces Challenges In A Crowded Market: Analyst
February 12, 2024
From Benzinga
From Motley Fool
From InvestorPlace
Assessing Sarepta Therapeutics: Insights From 12 Financial Analysts
January 30, 2024
Tickers
SRPT
From Benzinga
Sarepta Therapeutics' Next-Gen Duchenne Muscular Therapy Shows Efficacy At Less Frequent Dosing
January 29, 2024
From Benzinga
Got $3,000? 3 Growth Stocks to Double Up On Right Now
January 26, 2024
From Motley Fool
Could Sarepta Therapeutics Become the Next Vertex Pharmaceuticals?
January 25, 2024
From Motley Fool
Why Sarepta Therapeutics Stock Zoomed Nearly 5% Higher Today
January 22, 2024
From Motley Fool
From InvestorPlace
A Closer Look at 14 Analyst Recommendations For Sarepta Therapeutics
January 10, 2024
Tickers
SRPT
From Benzinga
Stocks Flip To Losses, Nvidia Defies Gravity, Bitcoin Pauses For A Breather: What's Driving Markets Tuesday?
January 09, 2024
From Benzinga
Sarepta Expects Prelim Gene Therapy Revenue To Be $131M In Q4, $200M For Fiscal Year
January 09, 2024
From Benzinga
Bumble (BMBL) Stock Pops as Elliott Builds a Stake in Rival Match
January 09, 2024
From InvestorPlace
Why Is Sarepta Therapeutics (SRPT) Stock Up Today?
January 09, 2024
From InvestorPlace
Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday
January 09, 2024
From Benzinga
2 Growth Stocks That Could Make You Richer in 2024 and Beyond
January 09, 2024
From Motley Fool
5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Monday
January 08, 2024
From Benzinga
Blood Cancer Player Arcellx Finds Place On Analyst Conviction List - Potential Room For Growth In 2024
January 04, 2024
From Benzinga
3 Things About Sarepta Therapeutics Every Smart Investor Knows
December 28, 2023
Tickers
SRPT
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
December 27, 2023
From Benzinga
Could Sarepta Therapeutics Be the Next Vertex Pharmaceuticals Stock?
December 22, 2023
From Motley Fool
1 Revolutionary Stock That Could Make You Richer in 2024 and Beyond
December 17, 2023
Tickers
SRPT
From Motley Fool
Could Sarepta Therapeutics Stock Help You Become a Millionaire?
December 09, 2023
Tickers
SRPT
From Motley Fool
My Take: 4 Strong Growth Stocks to Buy This Week
December 08, 2023
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
